心臟心律調節器市場規模、佔有率、成長分析，按類型、最終用戶、地區 - 行業預測，2024-2031 年

Cardiac Pacemaker Market Size, Share, Growth Analysis, By Type (External Pacemakers, Implantable Pacemakers), By End User (Hospitals, Cardiac Clinics), By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球心臟心律調節器市場規模估值為39.2億美元，從2023年的40.4億美元成長到2031年的51.6億美元，在預測期間（2024-2031年）預計複合年成長率為3.1% 。

由於心血管疾病盛行率上升和人口老化，全球心臟心律調節器市場正在顯著成長。生活方式改變等因素進一步增加心臟病的風險。技術的創新進步促進了微型無線心律調節器的發展，該起搏器具有遠端監控功能和自動生理調節功能。新興市場早期診斷意識的提高和醫療基礎設施的改善也有助於市場擴張。此外，研發投資的增加以及設備製造商和醫療保健提供者之間的合作也刺激了成長。然而，高昂的移植成本和偏遠地區的訪問受限等挑戰可能會阻礙市場成長。總體而言，由於持續的技術創新和向微創手術的轉變，預計市場將顯著成長。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Medtronic PLC
Abbott Laboratories
Boston Scientific Corporation
Biotronik SE & Co. KG
Lepu Medical Technology Co., Ltd.
LivaNova PLC
Osypka AG
Oscor Inc.
Pacetronix
Medico SRL
MicroPort Scientific Corporation
Shree Pacetronix Ltd.
ZOLL Medical Corporation
Asahi Kasei Corporation
OSYPKA Medical GmbH
Cardiac Science Corporation
EBR Systems, Inc.
BioTrace Medical, Inc.
Sorin Group（LivaNova）
Vitatron（Medtronic）

結論和建議

簡介目錄

Product Code: SQMIG35A2302

Global Cardiac Pacemaker Market size was valued at USD 3.92 billion in 2022 and is poised to grow from USD 4.04 billion in 2023 to USD 5.16 billion by 2031, growing at a CAGR of 3.1% during the forecast period (2024-2031).

The Global Cardiac Pacemaker Market is witnessing significant growth, driven by the rising prevalence of cardiovascular diseases and an aging population. Factors such as lifestyle changes are further escalating the risk of heart issues. Innovative advancements in technology have led to the development of smaller, wireless pacemakers featuring remote monitoring capabilities and automatic physiological adjustments. Increased awareness of early diagnosis and enhancements in healthcare infrastructure in developing regions also contribute to market expansion. Additionally, heightened investment in research and development, along with collaborations between device manufacturers and healthcare providers, is stimulating growth. However, challenges like high implantation costs and limited access in remote areas may hinder progress. Overall, the market is set for substantial growth due to ongoing innovations and a shift towards minimally invasive procedures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Pacemaker market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Pacemaker Market Segmental Analysis

Global Cardiac Pacemaker Market is segmented by type, end user and region. Based on type, the market is segmented into external pacemakers and implantable pacemakers. Based on end user, the market is segmented into hospitals, cardiac clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Pacemaker Market

One of the primary factors propelling the Global Cardiac Pacemaker Market is the rising prevalence of cardiovascular diseases. As the occurrence of heart-related issues such as arrhythmias and heart failure escalates around the world, the demand for cardiac pacemakers to effectively manage and treat these ailments intensifies. This trend is further exacerbated by lifestyle factors such as sedentary behavior, poor dietary choices, and an aging demographic, all of which collectively increase the incidence and burden of cardiovascular diseases globally. Consequently, the heightened need for innovative cardiac solutions significantly drives market growth and expansion.

Restraints in the Global Cardiac Pacemaker Market

A significant constraint within the Global Cardiac Pacemaker market is the elevated expenses linked to pacemaker implantation procedures. These advanced medical devices necessitate expertise from trained medical professionals along with specialized equipment and comprehensive post-operative care. The cumulative costs-including the pacemaker itself, surgical expenses, hospitalization, and subsequent follow-up-can be quite high, imposing a heavy financial strain on many patients. This economic hurdle limits access to essential cardiac care, especially for individuals in lower-income areas or those lacking sufficient insurance coverage, ultimately hindering the overall growth of the market.

Market Trends of the Global Cardiac Pacemaker Market

A prominent trend in the Global Cardiac Pacemaker Market is the rising adoption of remote monitoring technologies. This shift is fueled by the demand for continuous patient oversight and the urgent need for early detection of device malfunctions and abnormalities. Remote monitoring solutions allow healthcare providers to assess and track pacemaker performance in real-time, significantly improving patient care through timely interventions and minimizing the necessity for frequent hospital visits. The integration of advanced communication technologies and wireless connectivity has streamlined data transmission, enhancing patient outcomes and engagement. As a result, remote monitoring is becoming an essential feature in cardiac care strategies, shaping the future landscape of the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Case Studies
Trade Analysis

Global Cardiac Pacemaker Market Size by Type & CAGR (2024-2031)

Market Overview
External Pacemakers
- Single Chamber
- Dual Chamber
Implantable Pacemakers
- Conventional
- Leadless

Global Cardiac Pacemaker Market Size by End User & CAGR (2024-2031)

Market Overview
Hospitals
Cardiac Clinics
Ambulatory Surgery Centers
Others

Global Cardiac Pacemaker Market Size & CAGR (2024-2031)

North America (Type, End User)
- US
- Canada
Europe (Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Medtronic PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oscor Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacetronix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medico S.R.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shree Pacetronix Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZOLL Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Kasei Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OSYPKA Medical GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EBR Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioTrace Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sorin Group (LivaNova)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitatron (Medtronic)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments